SOPHiA: 3 Key Takeaways for Long-Term Investors
SOPHiA GENETICS SA (SOPH) Presents at 2026 UBS Global Healthcare Conference Transcript
SOPHiA GENETICS SA 2026 Q3 - Results - Earnings Call Presentation
Sophia Genetics SA (SOPH) (Q3 2026) Earnings Call Highlights: Revenue Surges 25% with Strong U. ...
SOPHiA GENETICS S.A. Q3 2026 Earnings Call Summary
SOPHiA (SOPH) Q3 2026 Earnings Call Transcript
SOPHiA GENETICS Q3 Earnings Call Highlights
SOPHiA GENETICS SA (SOPH) Q3 2026 Earnings Call Transcript
Sophia Genetics (NASDAQ:SOPH) Q3 2026: Revenue In Line, Wider Loss Weighs on Shares
SOPHiA GENETICS Reports Third Quarter 2026 Results
Sophia Genetics Q3 2026 Earnings Call Transcript
Sophia Genetics Raises FY2026 Sales Guidance from $94.000M-$96.000M to $96.000M vs $95.252M Est
Sophia Genetics Q3 EPS $(0.24) Misses $(0.18) Estimate, Sales $24.267M Beat $24.035M Estimate
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026
HC Wainwright & Co. Reiterates Buy on Sophia Genetics, Maintains $14 Price Target
SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetization Inflect
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript
AstraZeneca (LSE:AZN) Signs Two Cancer Diagnostics Deals To Widen Patient Access
SOPHiA GENETICS SA 2026 Q2 - Results - Earnings Call Presentation
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.